Social Sharing

It was the 10th Regina homicide reported in Saskatoon police initially arrested Bodechon in connection with an hour ago Record-breaking storm douses drought-stricken California SAN FRANCISCO AP — Across Northern California, crews worked Monday to clear streets of toppled trees and branches and to clean gutters clogged by debris carried by rainwater from a massive storm that caused flooding and rock slides, and knocked out power to hundreds of thousands.

Despite the problems, the rain and mountain snow were welcome in Northern California, which is so dry that nearly all of it is classified as either experiencing extreme or exceptional drought.

The wet weather also gre 21 hours ago Toronto police identify victim of shooting on Eglinton Avenue West Toronto police have released the name of the victim in a fatal shooting on Eglinton Avenue West early Saturday. Officers were called to Eglinton Ave. When police arrived, they found a man in an apartment who had been shot. Officers tried to save his life but he was pronounced dead at the scene. Marson is Toronto's 69th homicide victim of the year. Under the new guidance, employers should indicate if an employee quit code E or took a leave of absence code N on their ROE if the employee does not report to work because they source to comply with a mandatory COVID vaccination policy.

If an employer terminates an employee for not complying with its mandatory COVID vaccination policy, the employer should use code M dismissal.

Navigation menu

See more supports the view that a failure to comply with a vaccination policy without a valid exemption i. If an employer uses one of these codes, ESDC may reach out to determine the following: Has the employer adopted and clearly communicated to all employees a mandatory COVID vaccination policy? Were employees informed that failure to comply with the policy would result in loss of employment? Is the application of the policy to the employee reasonable within the workplace context? Are there any exemptions for refusing to comply with the policy? The great vaccination race is underway around the globe. Several drugmakers are racing to deliver on what they hope will be life-saving drugs.

DW breaks down what's going where.

Vaccination campaigns against COVID are gaining momentum across the world At least 73 vaccines to protect humans against the deadly coronavirus are currently in development globally, according to the COVID vaccine tracker run by a team of epidemologists and health experts at McGill Unviersity in Canada. Six drugs have passed the hurdles for public use in at least one country, while others have been in use for months without it.

Read on to learn more. Moderna The vaccine produced by the American biotech company Moderna was approved for public use in the US in December. Approval in the EU seems to be imminent, with European regulators planning to review the vaccine's status on January 6. Moderna has said it will produce the "vast majority" of its vaccine in Cambridge, Massachusetts, where the firm is based.

It plans to produce a minimum of million doses hotel near me open year, with a goal of producing as many as 1 billion doses in The European Union has ordered 80 million doses of the vaccine with an option of buying an additional 80 million, while the US has secured million doses with the option of purchasing another million. Canada, who has also approved the drug, has reserved 40 million doses. They expect to produce some 3 billion doses of their drug for use indirector of Oxford's Jenner Institute Adrian Hill said in November.

Is canada developing a vaccine for covid - sorry, this

Stage of development: Preclinical Entos Pharmaceuticals is a University of Alberta spinoff focused on genetic therapies. The body's cells then use those instructions to make coronavirus proteins, exposing the immune system to them so it can learn to recognize and fight off SARS-CoV DNA is more stable than RNA, which means it can be stored and shipped more easily, and it stays active in the body for longer.

But DNA needs to get into the nucleus of the cells in the body, and it's more complicated to is canada developing a vaccine for covid effectively.

Scientists across Canada are using a range of technologies to produce immunity against SARS-CoV-2

Entos's key technology is a way of delivering the DNA. DNA and RNA are typically packed into tiny spheres called lipid nanoparticles for delivery into the body. Entos's Fusogenix technology, on the other hand, is a "fusion protein" on the outside of the nanoparticle that fuses the nanoparticles with human cell membranes, freeing the DNA from the nanoparticle as it enters the cell. It also includes an adjuvant from Netherlands-based LiteVax. That generates a good immune response, she said. Currently, Canada lacks the capacity to manufacture the millions of doses of coronavirus vaccines needed to immunize people outside of a clinical trial setting.

View this post on Instagram

Shared post on Time